Session (CTI)

Healthcare decision makers have never faced greater expectations for rigorous, timely, and actionable evidence. As artificial intelligence accelerates evidence generation, real-world evidence becomes increasingly central to regulatory and HTA decisions, and healthcare systems face growing pressure to improve outcomes while managing finite resources, the science of health economics and outcomes research (HEOR) must continue to evolve to meet these demands. In this special forum, ISPOR leaders—including members of the Health Science Policy Council (HSPC)—will offer an exclusive preview of the Society's updated Science Strategy, a forward-looking framework designed to ensure that ISPOR remains at the forefront of scientific innovation and continues to meet the evolving evidence needs of healthcare decision makers around the world. This session will share the approach to its development, the emerging scientific priorities under consideration, and the opportunities where ISPOR can make its greatest contribution. Discussion will explore the future of artificial intelligence, real-world evidence, patient-centered methods, health technology assessment, evidence synthesis, and the next generation of ISPOR Good Practices and scientific initiatives. Importantly, this will be a conversation. ISPOR and the Health Science Policy Council leaders want to hear from the community about the proposed scientific priorities. If you care about where the science of HEOR is headed—and how ISPOR will lead it—this is a discussion you won't want to miss.